1. Home
  2. IMA vs WHWK Comparison

IMA vs WHWK Comparison

Compare IMA & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMA
  • WHWK
  • Stock Information
  • Founded
  • IMA 2019
  • WHWK 2007
  • Country
  • IMA United States
  • WHWK United States
  • Employees
  • IMA N/A
  • WHWK N/A
  • Industry
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • WHWK Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMA Health Care
  • WHWK Health Care
  • Exchange
  • IMA Nasdaq
  • WHWK Nasdaq
  • Market Cap
  • IMA 92.2M
  • WHWK 90.0M
  • IPO Year
  • IMA N/A
  • WHWK N/A
  • Fundamental
  • Price
  • IMA $8.60
  • WHWK $1.97
  • Analyst Decision
  • IMA
  • WHWK
  • Analyst Count
  • IMA 0
  • WHWK 0
  • Target Price
  • IMA N/A
  • WHWK N/A
  • AVG Volume (30 Days)
  • IMA 75.0K
  • WHWK 111.5K
  • Earning Date
  • IMA 11-15-2025
  • WHWK 11-15-2025
  • Dividend Yield
  • IMA N/A
  • WHWK N/A
  • EPS Growth
  • IMA N/A
  • WHWK N/A
  • EPS
  • IMA N/A
  • WHWK N/A
  • Revenue
  • IMA $4,300,000.00
  • WHWK $21,596,000.00
  • Revenue This Year
  • IMA N/A
  • WHWK N/A
  • Revenue Next Year
  • IMA N/A
  • WHWK N/A
  • P/E Ratio
  • IMA N/A
  • WHWK N/A
  • Revenue Growth
  • IMA N/A
  • WHWK N/A
  • 52 Week Low
  • IMA $7.57
  • WHWK $1.39
  • 52 Week High
  • IMA $23.28
  • WHWK $3.81
  • Technical
  • Relative Strength Index (RSI)
  • IMA N/A
  • WHWK 59.48
  • Support Level
  • IMA N/A
  • WHWK $1.82
  • Resistance Level
  • IMA N/A
  • WHWK $1.97
  • Average True Range (ATR)
  • IMA 0.00
  • WHWK 0.11
  • MACD
  • IMA 0.00
  • WHWK -0.00
  • Stochastic Oscillator
  • IMA 0.00
  • WHWK 76.74

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

About WHWK Whitehawk Therapeutics Inc. Common Stock

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Share on Social Networks: